Skip to main content

Table 1 Basic characteristic of the study groups

From: Quantitative assessment of left ventricular longitudinal function and myocardial deformation in Duchenne muscular dystrophy patients

  DMD n = 51 Controls n = 18 P value
Age (years) 14.7 ± 6.1 17.5 ± 2.9 0.064
Weight (kg) 49.1 ± 20.4 68.1 ± 10.5 4.10–4
Height (cm) 149 ± 19 177 ± 18 4.10–8
Dyspnoea (n (%)) 7 (13.7%) 0 (0%) 0.18
BMI (kg/m2) 21.3 ± 5.6 21.8 ± 2.2 0.73
Hypertension (n (%)) 3 (5.9%) 0 (0%) 0.56
Diabetes (n (%)) 0 (0%) 1 (5.6%) 0.26
Corticosteroids (n (%)) 22 (44.0%) 0 (0%) 3.10–4
ACE-inhibitors (n (%)) 18 (36.0%) 0 (0%) 2.10–3
ARBs (n (%)) 2 (4.0%) 0 (0%) 1.00
β-blockers (n (%)) 8 (16.0%) 0 (0%) 0.10
Diuretics (n (%)) 3 (6.0%) 0 (0%) 0.56
  1. Continuous variables are expressed as the mean ± standard deviation, binary variables as count (percentage). The p values refer to the t-test in the case of continuous variables or to Fisher exact test in binary variables. P-values < 0.05 are marked in bold.
  2. DMD, Duchenne muscular dystrophy; BMI, body mass index; ACE, angiotensin converting enzyme; ARB, angiotensin receptor blockers